Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing NMDAE plus AIFA with placebo for people with Schizophrenia. Participants receive NMDAE plus AIFA or placebo and complete study visits and assessments.
This study is looking at whether a digital support tool can help people with Clinical High Risk, Early Psychosis, or First Episode Psychosis. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This study is looking at assess the efficacy, safety, and tolerability of GXV813 in the treatment of an acute episode of schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Psychosis of Childhood Borderline or psychosis. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
This study is looking at investigate neural markers in the cerebellar-cortical circuitry that predict treatment response to antipsychotics in first-episode psychosis for people with Psychosis or Acute. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether MDMA 40mg can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This observational study is following people with Eating Disorders, mood conditions in Children and Adolescents, psychosis, or QTc Intervals Changes to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at investigate how atorvastatin affects glucose metabolism in schizophrenia patients and assess whether metformin can help improve these metabolic issues. Participants receive Atorvastatin or placebo and complete study visits and assessments.
This study is looking at evaluate the efficacy and safety of KarXT in acutely psychotic Japanese adult participants with schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether Xanomeline and Trospium Chloride Capsules can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a digital support tool can help people with psychosis or Schizophrenia Spectrum Disorders. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This study is looking at characterize the effect of KarXT on voiding dynamics and urological safety in participants with DSM-5 schizophrenia. Taking part may give some people access to Xanomeline/trospium chloride, but direct benefit is not guaranteed.
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether a digital support tool can help people with Paranoia or psychosis. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether ML-007C-MA can help people with Psychosis Associated With Alzheimer's Disease. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Acute (24-hour) abstinence can help people with Acute Abstinence From Cigarettes vs E-cigarettes. Participants take part in Acute (24-hour) abstinence and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with Treatment-resistant Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at care and outcomes for people with Schizophrenia or schizoaffective disorder. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This observational study is following people with Methamphetamine Use Disorder or Methamphetamine-induced Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is comparing NBI-1117570 with placebo for people with Schizophrenia. Participants receive NBI-1117570 or placebo and complete study visits and assessments.